Spearhead Capital Advisors’s Inspire Medical Systems INSP Stock Holding History

Spearhead Capital Advisors’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,234	Closed	-$225K	–	129
2022 Q2	$225K	Sell	1,234 -20	-2%	-$3.99K	0.03%	157
2022 Q1	$322K	Sell	1,254 -824	-40%	-$188K	0.04%	124
2021 Q4	$478K	Buy	2,078 +18	+0.9%	+$4.39K	0.06%	104
2021 Q3	$480K	Sell	2,060 -10	-0.5%	-$2.09K	0.06%	100
2021 Q2	$400K	Buy	2,070 +207	+11%	+$41.1K	0.05%	141
2021 Q1	$386K	Sell	1,863 -998	-35%	-$212K	0.06%	102
2020 Q4	$538K	Buy	2,861 +48	+2%	+$7.85K	0.09%	94
2020 Q3	$363K	Buy	2,813 +92	+3%	+$10.1K	0.07%	106
2020 Q2	$237K	Buy	+2,721	New	+$209K	0.05%	136

Other funds holding INSP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Spearhead Capital Advisors's INSP Position: Q3 2022 in Review

Spearhead Capital Advisors sold out of Inspire Medical Systems (INSP) in Q3 2022, closing a stake of 1,234 shares — an estimated $225K sold.

Spearhead Capital Advisors first reported a position in INSP in Q2 2020 and held it in 9 quarters. The position peaked at $538K in Q4 2020. 302 funds tracked by Wall St. Rank hold INSP as of Q3 2022.

Spearhead Capital Advisors reported no remaining Inspire Medical Systems position as of Q3 2022 after selling out during the quarter.
Spearhead Capital Advisors sold 1,234 Inspire Medical Systems shares in Q3 2022, an estimated $225K.
Spearhead Capital Advisors first reported a position in Inspire Medical Systems in Q2 2020 and held it in 9 quarters.
Spearhead Capital Advisors's Inspire Medical Systems position peaked at $538K in Q4 2020.
302 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2022.

Based on Spearhead Capital Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.